Loading the player...

1:59 MD /Alert Exclusive

NEXT UP
FDA Grants Orphan Drug Disease to Potential Alpha-1 Antitrypsin Deficiency Treatment

Pulmonology Health Inclusion and Diversity

Diversity and equality for faculty and trainees is critical among American Thoracic Society members worldwide.

Pulmonology experts from Penn Medicine, Stanford University, Yale, Johns Hopkins Medicine, and others, discuss how diversity is paramount to providing the best care within the communities they serve.

“We have to make the structural adjustments so that we fuel and populate our own pipelines,” said Enid Neptune, MD, associate professor of medicine, John Hopkins School of Medicine.

“The ATS as a society, has taken major steps to play a role in helping eliminate disparities through increasing health equity, diversity, and inclusion,” according to Juan Celedon, MD, Immediate Past President, American Thoracic Society.

Video Content: ATS
Video Source: EurekAlert

Next Up In Pulmonology

Integrating Transbronchial Lung Cryobiopsy into Multidisciplinary Discussion Impacts Diagnoses

Integrating Transbronchial Lung Cryobiopsy into Multidisciplinary Discussion Impacts Diagnoses

Hamilton Medical Issues Recall for Certain Ventilators Due to Software Issues

Hamilton Medical Issues Recall for Certain Ventilators Due to Software Issues

Mepolizumab for Severe Eosinophilic Asthma Shows Long-Term Efficacy

Mepolizumab for Severe Eosinophilic Asthma Shows Long-Term Efficacy

Combination LAMA-LABA Bests ICS-LABA Therapy Among Patients with COPD

Combination LAMA-LABA Bests ICS-LABA Therapy Among Patients with COPD

Airway Structural Differences May Contribute to COPD Symptom Burden

Airway Structural Differences May Contribute to COPD Symptom Burden

OCS Use in Patients with Asthma Linked to Increased Risk of Mortality

OCS Use in Patients with Asthma Linked to Increased Risk of Mortality

Clofazimine Improves Outcomes for Patients with Drug-Resistant TB

Clofazimine Improves Outcomes for Patients with Drug-Resistant TB

FDA Grants Breakthrough Therapy Designation to Novel Inhibitor for Idiopathic Pulmonary Fibrosis

FDA Grants Breakthrough Therapy Designation to Novel Inhibitor for Idiopathic Pulmonary Fibrosis

Artificial Intelligence Increases Diagnostic Efficiency of Pulmonologists

Artificial Intelligence Increases Diagnostic Efficiency of Pulmonologists

Inflammatory Markers May Point to Fibrosis After COVID-19 Infection

Inflammatory Markers May Point to Fibrosis After COVID-19 Infection

Combination Rescue Treatment Reduces Severe Asthma Exacerbations

Combination Rescue Treatment Reduces Severe Asthma Exacerbations

Oral Levosimendan Appears Safe, Effective in Pulmonary Hypertension and HFpEF

Oral Levosimendan Appears Safe, Effective in Pulmonary Hypertension and HFpEF

Respiratory Syncytial Virus Caused 100,000 Deaths in 2019 in Children 5 Years and Under

Respiratory Syncytial Virus Caused 100,000 Deaths in 2019 in Children 5 Years and Under

Off-Label Anticoagulant Use Presents Challenges

Off-Label Anticoagulant Use Presents Challenges

Fish Oil Supplementation Decreases Risk for COPD

Fish Oil Supplementation Decreases Risk for COPD

Bronchoscopic Lung Volume Reduction Improves Survival in Certain Patients with COPD

Bronchoscopic Lung Volume Reduction Improves Survival in Certain Patients with COPD

Data Shows Underreported Use of SABA in Patients with Uncontrolled Asthma

Data Shows Underreported Use of SABA in Patients with Uncontrolled Asthma

Vaccine for COPD Not Effective in Reducing Exacerbations

Vaccine for COPD Not Effective in Reducing Exacerbations

FDA Approves Mobile Radiography Device

FDA Approves Mobile Radiography Device

USPSTF Reaffirms Recommendation Against COPD Screening in Asymptomatic Individuals

USPSTF Reaffirms Recommendation Against COPD Screening in Asymptomatic Individuals

Pulmonology Health Inclusion and Diversity

Pulmonology Health Inclusion and Diversity

FDA Grants Orphan Drug Disease to Potential Alpha-1 Antitrypsin Deficiency Treatment

FDA Grants Orphan Drug Disease to Potential Alpha-1 Antitrypsin Deficiency Treatment

Significant Gaps Exist in Understanding Chronic Cough in Asthma, Other Conditions

Significant Gaps Exist in Understanding Chronic Cough in Asthma, Other Conditions

Respiratory Symptoms in Systemic Vasculitis Not One Size Fits All

Respiratory Symptoms in Systemic Vasculitis Not One Size Fits All

One in Eight Patients with Acute Pulmonary Embolism Also Have Atrial Fibrillation

One in Eight Patients with Acute Pulmonary Embolism Also Have Atrial Fibrillation

Two Respiratory Ventilation Systems Receive Class I Recall

Two Respiratory Ventilation Systems Receive Class I Recall

AI Collaboration Identifies Novel Target for Idiopathic Pulmonary Fibrosis

AI Collaboration Identifies Novel Target for Idiopathic Pulmonary Fibrosis

ESC/ERS Guidelines Recommend New Diagnostic Algorithm for Pulmonary Hypertension

ESC/ERS Guidelines Recommend New Diagnostic Algorithm for Pulmonary Hypertension

Oral PDE4 Inhibitor Slows FVC Decline in Patients with Idiopathic Pulmonary Fibrosis

Oral PDE4 Inhibitor Slows FVC Decline in Patients with Idiopathic Pulmonary Fibrosis

Strados Labs Gains FDA 510(k) Clearance for Smart Sensor Platform to Monitor Respiratory Health

Strados Labs Gains FDA 510(k) Clearance for Smart Sensor Platform to Monitor Respiratory Health

Gene Mutations in Patients with Idiopathic Pulmonary Fibrosis

Gene Mutations in Patients with Idiopathic Pulmonary Fibrosis

FDA Grants Approval for Generic Equivalent in COPD

FDA Grants Approval for Generic Equivalent in COPD

Noninvasive Clinical Tools Predict Pulmonary Hypertension in COPD

Noninvasive Clinical Tools Predict Pulmonary Hypertension in COPD

Salbutamol Treatment Timing May Improve Bronchodilation for Patients with Asthma

Salbutamol Treatment Timing May Improve Bronchodilation for Patients with Asthma

Genetic Marker for Early Intervention in Hypersensitivity Pneumonitis

Genetic Marker for Early Intervention in Hypersensitivity Pneumonitis

Lung Transplant Beneficial for COVID-19-Related Severe Lung Damage

Lung Transplant Beneficial for COVID-19-Related Severe Lung Damage

MD /alert Exclusives

Hamilton Medical Issues Recall for Certain Ventilators Due to Software Issues

Hamilton Medical Issues Recall for Certain Ventilators Due to Software Issues

Mepolizumab for Severe Eosinophilic Asthma Shows Long-Term Efficacy

Mepolizumab for Severe Eosinophilic Asthma Shows Long-Term Efficacy

Integrating Transbronchial Lung Cryobiopsy into Multidisciplinary Discussion Impacts Diagnoses

Integrating Transbronchial Lung Cryobiopsy into Multidisciplinary Discussion Impacts Diagnoses

Combination LAMA-LABA Bests ICS-LABA Therapy Among Patients with COPD

Combination LAMA-LABA Bests ICS-LABA Therapy Among Patients with COPD

Significant Gaps Exist in Understanding Chronic Cough in Asthma, Other Conditions

Significant Gaps Exist in Understanding Chronic Cough in Asthma, Other Conditions

Fish Oil Supplementation Decreases Risk for COPD

Fish Oil Supplementation Decreases Risk for COPD

Oral Levosimendan Appears Safe, Effective in Pulmonary Hypertension and HFpEF

Oral Levosimendan Appears Safe, Effective in Pulmonary Hypertension and HFpEF

Salbutamol Treatment Timing May Improve Bronchodilation for Patients with Asthma

Salbutamol Treatment Timing May Improve Bronchodilation for Patients with Asthma

OCS Use in Patients with Asthma Linked to Increased Risk of Mortality

OCS Use in Patients with Asthma Linked to Increased Risk of Mortality

ESC/ERS Guidelines Recommend New Diagnostic Algorithm for Pulmonary Hypertension

ESC/ERS Guidelines Recommend New Diagnostic Algorithm for Pulmonary Hypertension

One in Eight Patients with Acute Pulmonary Embolism Also Have Atrial Fibrillation

One in Eight Patients with Acute Pulmonary Embolism Also Have Atrial Fibrillation

Clofazimine Improves Outcomes for Patients with Drug-Resistant TB

Clofazimine Improves Outcomes for Patients with Drug-Resistant TB

Airway Structural Differences May Contribute to COPD Symptom Burden

Airway Structural Differences May Contribute to COPD Symptom Burden

Two Respiratory Ventilation Systems Receive Class I Recall

Two Respiratory Ventilation Systems Receive Class I Recall

Oral PDE4 Inhibitor Slows FVC Decline in Patients with Idiopathic Pulmonary Fibrosis

Oral PDE4 Inhibitor Slows FVC Decline in Patients with Idiopathic Pulmonary Fibrosis

Bronchoscopic Lung Volume Reduction Improves Survival in Certain Patients with COPD

Bronchoscopic Lung Volume Reduction Improves Survival in Certain Patients with COPD

Respiratory Syncytial Virus Caused 100,000 Deaths in 2019 in Children 5 Years and Under

Respiratory Syncytial Virus Caused 100,000 Deaths in 2019 in Children 5 Years and Under

FDA Approves Mobile Radiography Device

FDA Approves Mobile Radiography Device

USPSTF Reaffirms Recommendation Against COPD Screening in Asymptomatic Individuals

USPSTF Reaffirms Recommendation Against COPD Screening in Asymptomatic Individuals

Combination Rescue Treatment Reduces Severe Asthma Exacerbations

Combination Rescue Treatment Reduces Severe Asthma Exacerbations

Data Shows Underreported Use of SABA in Patients with Uncontrolled Asthma

Data Shows Underreported Use of SABA in Patients with Uncontrolled Asthma

Strados Labs Gains FDA 510(k) Clearance for Smart Sensor Platform to Monitor Respiratory Health

Strados Labs Gains FDA 510(k) Clearance for Smart Sensor Platform to Monitor Respiratory Health

Artificial Intelligence Increases Diagnostic Efficiency of Pulmonologists

Artificial Intelligence Increases Diagnostic Efficiency of Pulmonologists

FDA Grants Orphan Drug Disease to Potential Alpha-1 Antitrypsin Deficiency Treatment

FDA Grants Orphan Drug Disease to Potential Alpha-1 Antitrypsin Deficiency Treatment

FDA Grants Approval for Generic Equivalent in COPD

FDA Grants Approval for Generic Equivalent in COPD

Lung Transplant Beneficial for COVID-19-Related Severe Lung Damage

Lung Transplant Beneficial for COVID-19-Related Severe Lung Damage

FDA Grants Breakthrough Therapy Designation to Novel Inhibitor for Idiopathic Pulmonary Fibrosis

FDA Grants Breakthrough Therapy Designation to Novel Inhibitor for Idiopathic Pulmonary Fibrosis

Noninvasive Clinical Tools Predict Pulmonary Hypertension in COPD

Noninvasive Clinical Tools Predict Pulmonary Hypertension in COPD

Off-Label Anticoagulant Use Presents Challenges

Off-Label Anticoagulant Use Presents Challenges

Vaccine for COPD Not Effective in Reducing Exacerbations

Vaccine for COPD Not Effective in Reducing Exacerbations

AI Collaboration Identifies Novel Target for Idiopathic Pulmonary Fibrosis

AI Collaboration Identifies Novel Target for Idiopathic Pulmonary Fibrosis

Inflammatory Markers May Point to Fibrosis After COVID-19 Infection

Inflammatory Markers May Point to Fibrosis After COVID-19 Infection

Breaking Research

Genetic Marker for Early Intervention in Hypersensitivity Pneumonitis

Genetic Marker for Early Intervention in Hypersensitivity Pneumonitis

Pulmonology Health Inclusion and Diversity

Pulmonology Health Inclusion and Diversity

Curated For You

Respiratory Symptoms in Systemic Vasculitis Not One Size Fits All

Respiratory Symptoms in Systemic Vasculitis Not One Size Fits All

Gene Mutations in Patients with Idiopathic Pulmonary Fibrosis

Gene Mutations in Patients with Idiopathic Pulmonary Fibrosis